JP Morgan Chase’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding HEAL
WWM
PCA
IWM
FFA
JP Morgan Chase's HEAL Position: Q1 2026 in Review
JP Morgan Chase reduced its Global X Funds Global X HealthTech ETF (HEAL) stake by 3.3% in Q1 2026, selling an estimated $544 and leaving 586 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6660.
JP Morgan Chase first reported a position in HEAL in Q1 2022 and has held it in 17 quarters since. The position peaked at $38.4K in Q1 2023. 30 funds tracked by Wall St. Rank hold HEAL as of Q1 2026.
- JP Morgan Chase held 586 shares of Global X Funds Global X HealthTech ETF worth $13.6K as of Q1 2026.
- JP Morgan Chase sold 20 Global X Funds Global X HealthTech ETF shares in Q1 2026, an estimated $544.
- Global X Funds Global X HealthTech ETF made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6660 holding.
- JP Morgan Chase first reported a position in Global X Funds Global X HealthTech ETF in Q1 2022 and has held it in 17 quarters since.
- JP Morgan Chase's Global X Funds Global X HealthTech ETF position peaked at $38.4K in Q1 2023.
- 30 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.